Evaluation of an Online Mindfulness Program for People with MS
Type of Study/Intervention
Form of MS
Relapsing remitting MS, Secondary progressive MS, Primary progressive MS
Online Mindfulness Program for People with MS
What? Mindfulness involves the daily practice of meditation, which is a mental exercise that is thought to improve the mind’s ability to focus by paying attention to the present moment, without judgment.
Why? We know that MS can take a toll on your mental and physical health. Mindfulness-based programs have been shown to be effective for improving depression, anxiety, fatigue, pain and quality of life for people with a range of chronic illnesses. However, little is known about the efficacy of online mindfulness programs for people with MS.
How? We are conducting a randomised controlled trial, which means that if you take part, you have a 50% chance that you will be asked to complete the 8-week online program and a 50% chance that you will be placed in the waitlist group, where you will receive the program later.
Where? You can participate from anywhere in Australia, as long as you have access to the Internet.
People with MS are eligible if they :
- Have a neurologist-confirmed diagnosis of MS
- Are ≥ 18 years old
- Have regular access to the Internet
- Have sufficient English language skills to complete questionnaires and understand the program in English
People with MS are not eligible if they:
- Have another medical condition known to impact on cognition or physical ability
- Have moderate or severe cognitive problems
- Have serious mental health problems e.g. that may require emergency care or a psychotic illness.
- Have received consistent (e.g. weekly) psychotherapy within the last 6 months
Anticipated start date
If you are interested in finding out more, and whether you are eligible to participate, please register your interest by clicking the link below:
Or contact: Amy-Lee Sesel (The University of Sydney)
Email: [email protected]
Phone: 0413 076 177
Full details of the trial can be found on the ANZCTR clinical trials database: